- Home
- OFG vs BCYC Comparison
OFG vs BCYC Comparison
Compare OFG & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFG
- BCYC
- Stock Information
- Founded
- OFG 1964
- BCYC 2009
- Country
- OFG United States
- BCYC United Kingdom
- Employees
- OFG N/A
- BCYC N/A
- Industry
- OFG Major Banks
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- OFG Finance
- BCYC Health Care
- Exchange
- OFG Nasdaq
- BCYC Nasdaq
- Market Cap
- OFG 2.0B
- BCYC 1.7B
- IPO Year
- OFG N/A
- BCYC 2019
- Fundamental
- Price
- OFG $44.21
- BCYC $13.34
- Analyst Decision
- OFG Buy
- BCYC Buy
- Analyst Count
- OFG 3
- BCYC 9
- Target Price
- OFG $48.33
- BCYC $34.50
- AVG Volume (30 Days)
- OFG 364.1K
- BCYC 417.9K
- Earning Date
- OFG 01-22-2025
- BCYC 02-18-2025
- Dividend Yield
- OFG 2.26%
- BCYC N/A
- EPS Growth
- OFG 8.35
- BCYC N/A
- EPS
- OFG 4.13
- BCYC N/A
- Revenue
- OFG $639,464,000.00
- BCYC $36,898,000.00
- Revenue This Year
- OFG N/A
- BCYC $40.69
- Revenue Next Year
- OFG $1.02
- BCYC N/A
- P/E Ratio
- OFG $10.71
- BCYC N/A
- Revenue Growth
- OFG 2.17
- BCYC 48.60
- 52 Week Low
- OFG $33.19
- BCYC $12.17
- 52 Week High
- OFG $47.66
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- OFG 58.38
- BCYC 34.88
- Support Level
- OFG $42.84
- BCYC $13.20
- Resistance Level
- OFG $44.18
- BCYC $15.43
- Average True Range (ATR)
- OFG 1.09
- BCYC 0.89
- MACD
- OFG 0.26
- BCYC 0.16
- Stochastic Oscillator
- OFG 97.83
- BCYC 6.17
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. It provides services in the region of Puerto Rico.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.